Timothy Semple
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.
Journal: Leukemia
Published: December 12, 2025
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
Journal: Nature communications
Published: November 21, 2025
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.
Journal: The Journal of pathology
Published: October 28, 2025
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression.
Journal: The Journal of pathology
Published: December 05, 2024
MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 24, 2023
TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 09, 2022
Single-Cell Gene Expression, Clonality, and Feature Barcoding of Melanoma Tumor-Infiltrating Lymphocytes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2021
Non-genetic determinants of malignant clonal fitness at single-cell resolution.
Journal: Nature
Published: November 09, 2020
SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells.
Journal: Science advances
Published: August 18, 2020
Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing.
Journal: Haematologica
Published: August 13, 2020
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Journal: Cancer discovery
Published: August 10, 2020
Last Updated: 09/26/2026